Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.


Category: Epidemiology-Outcomes

The Effects of ICU Crisis Reorganization on Outcomes in Patients Not Infected With Coronavirus Disease 2019 During the Initial Surge of the Coronavirus Disease 2019 Pandemic

From Critical Care Explorations . In this study, the authors determined if ICU reorganization due to the coronavirus disease 2019 pandemic affected outcomes in critically ill patients who were not infected with coronavirus disease 2019.

   Estimated Time: 16:52 Coronavirus, COVID-19, Resource Allocation

Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis

From Critical Care Explorations .  In this study, the authors evaluate ICU mortality at 28 days in patients with severe hypoxemic respiratory failure due to coronavirus disease 2019 infection who received tocilizumab. 

   Estimated Time: 33:18

The Impact of the Novel Coronavirus on Brazilian PICUs

From Pediatric Critical Care Medicine.  The authors evaluated the impact of the coronavirus disease 2019 pandemic, considering the physical distancing and schools closing, on the characteristics of admission and epidemiology on Brazilian PICUs.  

   Estimated Time: 13:08 Coronavirus, COVID-19, pediatrics

Tokyo and New York: A Study in the Contrasting Effects of Socioeconomic Status on Coronavirus Disease 2019 Outcomes

From Critical Care Explorations.  The authors examined the association between socioeconomic status and the rate of coronavirus disease 2019 infections using public data from Tokyo.

   Estimated Time: 9:57 Coronavirus, COVID-19, Infection Control, Statistics

Nationwide Incidence and Outcomes of Patients With Coronavirus Disease 2019 Requiring Intensive Care in Iceland

From Critical Care Medicine. In this study from Iceland, which had early adoption of widespread testing, the authors report a lower overall ratio of ICU admissions for coronavirus disease 2019 among severe acute respiratory syndrome coronavirus 2 positive patients and a lower ...

   Estimated Time: 10:24 min Coronavirus, COVID-19, Statistics

How effective are medications that target interleukin-6?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on June 10th, 2020.

   Estimated Time: 01:57 min Coronavirus, COVID-19, Therapies

Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019

Cytokine release syndrome (CRS) mediated by IL-6 is a critical driver of COVID-19 mortality. The authors review and discuss key immunologic effects of direct IL-6 blockade, downstream non-selective JAK inhibition, and selective JAK2 suppression to treat COVID-19-related CRS.

   Estimated Time: 12:04 min Comorbidities, Coronavirus, COVID-19, Diagnosis and Testing

Age Distribution and Critical Illness Severity of COVID-19

This presentation is an overview of age distribution as it relates to severity in COVID-19 patients.

   Estimated Time: 7:54 min Clinical presentations, Coronavirus, COVID-19, Statistics